SCHEMBL379262

SCHEMBL379262

C#CCC(CC#C)(C(=O)OCC)C(=O)OCC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
ALDH1A1 P00352 4/20 0.39
PKM P14618 3/20 0.37
KDM4E B2RXH2 1/20 0.37
LMNA P02545 2/20 0.37
HSD17B10 Q99714 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.36
CYP4F2 P78329 2/20 0.36
CYP4A11 Q02928 2/20 0.36
THRB P10828 1/20 0.36
ALOX15 P16050 1/20 0.36
MGAM O43451 1/20 0.36
GAA P10253 1/20 0.36
SI P14410 1/20 0.36
MGAM2 Q2M2H8 1/20 0.36
SOAT1 P35610 1/20 0.36
HTT P42858 1/20 0.35
TSHR P16473 1/20 0.35
PIN1 Q13526 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1026954 0.90 MEN1 (0.46) MEN1KMT2AALDH1A1PKMKDM4E
SCHEMBL27861619 0.90 MEN1 (0.46) MEN1KMT2AALDH1A1PKMKDM4E
SCHEMBL13259175 0.89 MEN1 (0.42) MEN1KMT2AALDH1A1PKMKDM4E
SCHEMBL10907546 0.85 MEN1 (0.46) MEN1KMT2AALDH1A1PKMKDM4E
SCHEMBL13259160 0.85 MEN1 (0.39) MEN1KMT2AL3MBTL1
SCHEMBL28481211 0.84 MEN1 (0.41) MEN1KMT2AALDH1A1PKMKDM4E
SCHEMBL5820577 0.84 MEN1 (0.41) MEN1KMT2AALDH1A1PKMKDM4E
SCHEMBL13259358 0.83 MEN1 (0.41) MEN1KMT2AALDH1A1PKMKDM4E
SCHEMBL17212019 0.83 MEN1 (0.41) MEN1KMT2AALDH1A1PKMKDM4E
SCHEMBL13622353 0.83 MEN1 (0.41) MEN1KMT2AALDH1A1PKMKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006117800-A2 NOVEL 3, 4-PROPYLENEDIOXYTHIOPHENE DERIVATIVES WITH PENDANT FUNCTIONAL GROUPS INDIAN INSTITUTE OF TECHNOLOGY BOMBAY (IN) 2006-11-09 WO claimed
US-20240190880-A1 SMALL MOLECULE DEGRADERS OF ESTROGEN RECEPTOR WITH CEREBLON LIGANDS REGENTS OF THE UNIVERSITY OF MICHIGAN 2024-06-13 US disclosed
US-20240150360-A1 Small Molecule Degraders of CBP/p300 Proteins THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2024-05-09 US disclosed
US-20230357249-A1 ANDROGEN RECEPTOR PROTEIN DEGRADERS WITH A TRICYCLIC CEREBLON LIGAND UNIV MICHIGAN REGENTS (US) 2023-11-09 US disclosed
US-20230357249-A1 ANDROGEN RECEPTOR PROTEIN DEGRADERS WITH A TRICYCLIC CEREBLON LIGAND UNIV MICHIGAN REGENTS (US) 2023-11-09 US disclosed
US-20230357249-A1 ANDROGEN RECEPTOR PROTEIN DEGRADERS WITH A TRICYCLIC CEREBLON LIGAND UNIV MICHIGAN REGENTS (US) 2023-11-09 US disclosed
US-20220388978-A1 CEREBLON E3 LIGASE INHIBITORS REGENTS OF THE UNIVERSITY OF MICHIGAN 2022-12-08 US disclosed
US-20220388978-A1 CEREBLON E3 LIGASE INHIBITORS REGENTS OF THE UNIVERSITY OF MICHIGAN 2022-12-08 US disclosed
US-20220380368-A1 SPIROCYCLIC ANDROGEN RECEPTOR PROTEIN DEGRADERS REGENTS OF THE UNIVERSITY OF MICHIGAN 2022-12-01 US disclosed
WO-2022187417-A1 SMALL MOLECULE DEGRADERS OF CBP/P300 PROTEINS THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2022-09-09 WO disclosed
US-20100029888-A1 Click-Reaction Crosslinkable Multicomponent Silicone Compositions WACKER CHEMIE AG (DE) 2010-02-04 US disclosed
WO-2009135449-A1 LIGANDS OF ESTROGEN RECEPTORS α AND β, METHOD OF THEIR PREPARATION AND PHARMACEUTICALS COMPRISING THEM USTAV MOLEKULARNI GENETIKY AV CR, V.V.I. (CZ) 2009-11-12 WO disclosed
WO-2009135449-A1 LIGANDS OF ESTROGEN RECEPTORS α AND β, METHOD OF THEIR PREPARATION AND PHARMACEUTICALS COMPRISING THEM USTAV MOLEKULARNI GENETIKY AV CR, V.V.I. (CZ) 2009-11-12 WO disclosed
CN-101412667-A Preparation of 2-pimelie kelone compound UNIV ZHEJIANG TECHNOLOGY (CN) 2009-04-22 CN disclosed
CN-100448841-C Process for preparing 2-cyclohexenone compounds UNIV ZHEJIANG (CN) 2009-01-07 CN disclosed
CN-101104587-A 2-cyclohexenone compounds UNIV ZHEJIANG (CN) 2008-01-16 CN disclosed
CN-100358857-C 2-cyclohexenone compounds and preparation method thereof UNIV ZHEJIANG (CN) 2008-01-02 CN disclosed
CN-1951903-A Process for preparing 2-cyclohexenone compounds UNIV ZHEJIANG (CN) 2007-04-25 CN disclosed
WO-2006117800-A2 NOVEL 3, 4-PROPYLENEDIOXYTHIOPHENE DERIVATIVES WITH PENDANT FUNCTIONAL GROUPS INDIAN INSTITUTE OF TECHNOLOGY BOMBAY (IN) 2006-11-09 WO disclosed
CN-1827577-A 2-cyclohexenone compounds and preparation method thereof UNIV ZHEJIANG (CN) 2006-09-06 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230357249-A1 ANDROGEN RECEPTOR PROTEIN DEGRADERS WITH A TRICYCLIC CEREBLON LIGAND AR, GPER1, CRBN MEN1 497/4885KMT2A 3389/4885ALDH1A1 291/4885
US-20220380368-A1 SPIROCYCLIC ANDROGEN RECEPTOR PROTEIN DEGRADERS AR, NR5A1, ESRRA MEN1 659/4885KMT2A 1043/4885ALDH1A1 132/4885
US-20240150360-A1 Small Molecule Degraders of CBP/p300 Proteins EP300, CREBBP, NCOR1 MEN1 1750/4885KMT2A 291/4885ALDH1A1 2142/4885
US-20240190880-A1 SMALL MOLECULE DEGRADERS OF ESTROGEN RECEPTOR WITH CEREBLON LIGANDS ESR1, CRBN, ESR2 MEN1 924/4885KMT2A 1525/4885ALDH1A1 1261/4885
US-20220388978-A1 CEREBLON E3 LIGASE INHIBITORS CRBN, CUL3, UBE3A MEN1 739/4885KMT2A 318/4885ALDH1A1 3487/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.